ProfileGDS4095 / 217553_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 26% 36% 30% 36% 40% 37% 30% 35% 29% 32% 29% 41% 33% 34% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.2145926
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.5719736
GSM709765LY2 SRC1-siRNA untreated rep32.3757630
GSM709771LY2 SRC1-siRNA untreated rep12.5742736
GSM709772LY2 SRC1-siRNA untreated rep22.7581640
GSM709775LY2 SRC1-siRNA untreated rep42.6103837
GSM709764LY2 control-siRNA tamoxifen treated rep22.3769630
GSM709766LY2 control-siRNA tamoxifen treated rep32.5696935
GSM709768LY2 control-siRNA tamoxifen treated rep12.3194729
GSM709777LY2 control-siRNA tamoxifen treated rep42.4216132
GSM709770LY2 control-siRNA untreated rep32.3025629
GSM709773LY2 control-siRNA untreated rep12.8329341
GSM709774LY2 control-siRNA untreated rep22.4616533
GSM709776LY2 control-siRNA untreated rep42.4930234